340 related articles for article (PubMed ID: 30502256)
1. Symptom Resolution and Volumetric Reduction of Abdominal Lymphatic Malformations With Sclerotherapy.
Madsen HJ; Annam A; Harned R; Nakano TA; Larroque LO; Kulungowski AM
J Surg Res; 2019 Jan; 233():256-261. PubMed ID: 30502256
[TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy of abdominal lymphatic malformations with doxycycline.
Chaudry G; Burrows PE; Padua HM; Dillon BJ; Fishman SJ; Alomari AI
J Vasc Interv Radiol; 2011 Oct; 22(10):1431-5. PubMed ID: 21821431
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline Sclerotherapy Is Superior in the Treatment of Pediatric Lymphatic Malformations.
Thomas DM; Wieck MM; Grant CN; Dossa A; Nowicki D; Stanley P; Zeinati C; Howell LK; Anselmo DM
J Vasc Interv Radiol; 2016 Dec; 27(12):1846-1856. PubMed ID: 27776983
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.
Shergill A; John P; Amaral JG
Pediatr Radiol; 2012 Sep; 42(9):1080-8. PubMed ID: 22648390
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children.
Nehra D; Jacobson L; Barnes P; Mallory B; Albanese CT; Sylvester KG
J Pediatr Surg; 2008 Mar; 43(3):451-60. PubMed ID: 18358281
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline sclerotherapy for pediatric head and neck macrocystic lymphatic malformations: a case series and review of the literature.
Jamal N; Ahmed S; Miller T; Bent J; Brook A; Parikh S; Ankola A
Int J Pediatr Otorhinolaryngol; 2012 Aug; 76(8):1127-31. PubMed ID: 22572407
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy for intra-abdominal lymphatic malformations in children.
Russell KW; Rollins MD; Feola GP; Arnold R; Barnhart DC; Scaife ER
Eur J Pediatr Surg; 2014 Aug; 24(4):317-21. PubMed ID: 23846982
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population.
Tu JH; Do HM; Patel V; Yeom KW; Teng JMC
J Neurointerv Surg; 2017 Oct; 9(10):1023-1026. PubMed ID: 27707871
[TBL] [Abstract][Full Text] [Related]
12. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.
Shiels WE; Kenney BD; Caniano DA; Besner GE
J Pediatr Surg; 2008 Jan; 43(1):136-9; discussion 140. PubMed ID: 18206471
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.
Farnoosh S; Don D; Koempel J; Panossian A; Anselmo D; Stanley P
Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):883-887. PubMed ID: 25887132
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement.
Alomari AI; Karian VE; Lord DJ; Padua HM; Burrows PE
J Vasc Interv Radiol; 2006 Oct; 17(10):1639-48. PubMed ID: 17057006
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous treatment of lymphatic malformations.
Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience.
Barnacle AM; Theodorou M; Maling SJ; Abou-Rayyah Y
Br J Ophthalmol; 2016 Feb; 100(2):204-8. PubMed ID: 26085546
[TBL] [Abstract][Full Text] [Related]
18. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
19. OK432 versus doxycycline for treatment of macrocystic lymphatic malformations.
Motz KM; Nickley KB; Bedwell JR; Yadav B; Guzzetta PC; Oh AK; Bauman NM
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):81-8. PubMed ID: 24574462
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous sclerotherapy of lymphatic malformations with doxycycline.
Burrows PE; Mitri RK; Alomari A; Padua HM; Lord DJ; Sylvia MB; Fishman SJ; Mulliken JB
Lymphat Res Biol; 2008; 6(3-4):209-16. PubMed ID: 19093794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
